CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 60 enrolled
Drug / intervention
Ketamine-Morphine +1 moredrug
Likely dose
Ketamine-Morphine 0.5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06010056
NCT06010056Phase 4Completed

PCA Ketamine-Morphine Versus PCA Morphine as Post-Operative Analgesia in Colorectal Surgery.

National University of Malaysia·interventional·Posted Aug 24, 2023·Updated Aug 24, 2023

In Brief

A Phase 4 clinical trial evaluating Ketamine-Morphine and Morphine for Ketamine and Morphine. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to compare the effectiveness of PCA ketamine-morphine versus conventional PCA morphine in postoperative patients undergoing elective laparotomy colorectal surgery under general anaesthesia. The specific objectives are: 1. To compare the postoperative analgesic requirement with PCA ketamine-morphine in comparison with PCA morphine. 2. To compare the postoperative pain scores between PCA ketamine-morphine and PCA morphine. 3. To assess patients' overall satisfaction with PCA ketamine-morphine in comparison with PCA morphine. 4. To study the incidence of side effects of PCA ketamine-morphine in comparison with PCA morphine. Participants will be screened and recruited at the pre-anaesthetic clinic (PAC). Those who consented will be taught to use the PCA machine and the potential side effects of the study drugs. They will be randomly allocated into either Group A or Group B by computer-generated randomization a day before planned surgery. Researchers will compare Group A and Group B to see post-operative pain scores, patients' overall satisfaction and any incidence of side effects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKetamine, Morphine
CountriesMalaysia
Collaborators--

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedAug 24, 2023
Enrollment StartApr 5, 2018
Primary CompletionApr 4, 2019
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 2.9 years ago

Interventions

Ketamine-Morphinedrug

PCA ketamine (Ketamine HCl, Pfizer Inc., US) 0.5 mg plus morphine 0.5 mg ml-1 (ratio 1:1)

Morphinedrug

PCA morphine (Pfizer Inc., US) 1 mg ml-1